2-시아노-5-플루오로벤질 브로마이드 시장 : 세계 예측(2026-2032년)

The 2-Cyano-5-Fluorobenzyl Bromide Market is projected to grow by USD 156.62 million at a CAGR of 5.50% by 2032.

2-Cyano-5-Fluorobenzyl Bromide: Executive Overview

2-Cyano-5-fluorobenzyl bromide is a specialized halogenated aromatic building block used in research and chemical synthesis. Its value proposition is linked to the combined reactivity of a benzyl bromide group, a nitrile group, and a fluorinated aromatic ring, which can support the preparation of more complex intermediates. Demand conditions are shaped by pharmaceutical and agrochemical research activity, specialty chemical development, laboratory procurement practices, regulatory requirements, and the availability of qualified synthesis and analytical capabilities. Because public information on this narrowly defined compound is limited, conclusions should be interpreted as directional rather than as a substitute for product-specific transaction data.

Synthesis Complexity and Supply-Chain Discipline Are Reshaping the Landscape

The landscape is being transformed by tighter expectations for identity, purity, traceability, and documentation. Buyers increasingly evaluate suppliers not only on stated specifications but also on lot consistency, analytical packages, packaging integrity, storage conditions, and the ability to manage controlled or hazardous intermediates. The compound's reactive benzyl bromide functionality also raises practical considerations around moisture exposure, handling, transport classification, and shelf-life management. These factors encourage closer coordination among researchers, custom synthesis providers, distributors, and quality teams.

Artificial Intelligence Accelerates Discovery, Quality Control, and Procurement Decisions

Artificial intelligence can influence this market through reaction-route design, structure-based analogue selection, literature mining, and prediction of likely synthetic outcomes. Machine-learning tools may also assist with spectral interpretation, impurity detection, inventory optimization, supplier qualification, and demand prioritization. However, computational outputs require experimental validation because reaction performance can vary with substrate choice, scale, solvent, catalyst, temperature, and work-up conditions. Practical adoption therefore depends on integrating AI with validated laboratory workflows, secure data governance, human review, and auditable quality systems.

Regional Insights: Regulation, Research Intensity, and Logistics Shape Adoption

North America combines strong pharmaceutical research capabilities with sophisticated procurement and compliance processes, supporting demand for documented specialty intermediates. Latin America presents opportunities linked to expanding research and industrial networks, while import dependence, customs complexity, and local analytical capacity can affect availability. Europe emphasizes chemical safety, traceability, and sustainability, making regulatory documentation and responsible handling particularly important. The Middle East is developing specialized research and manufacturing capabilities, but supply continuity and technical support remain relevant considerations. Africa shows a more varied landscape, with access influenced by institutional capacity, import channels, and laboratory infrastructure. Asia-Pacific includes extensive pharmaceutical and chemical production ecosystems, although requirements differ substantially across markets and suppliers must address varied regulatory, quality, and logistics expectations.

Group Insights: Trade Integration and Regulatory Alignment Create Different Operating Priorities

ASEAN markets offer interconnected manufacturing and research pathways, but product registration, import procedures, and technical standards can differ among members. BRICS economies provide diverse industrial and scientific bases, with opportunities shaped by domestic capability, bilateral trade arrangements, and local compliance requirements. The European Union benefits from regulatory harmonization while maintaining demanding expectations for chemical safety and documentation. G7 markets generally emphasize advanced research, supplier qualification, environmental compliance, and resilient sourcing. GCC markets are strengthening scientific and industrial infrastructure, with procurement often influenced by import logistics, localization goals, and institutional partnerships. NATO members are not a single commercial or regulatory market, yet their overlapping emphasis on supply-chain resilience, security, and high-quality technical inputs can affect strategic sourcing decisions.

Country Insights: Capabilities and Compliance Conditions Differ Across Major Markets

Australia's research institutions and specialty import channels support use in advanced laboratory applications. Brazil combines a substantial industrial base with regulatory and customs considerations that can influence lead times. Canada's research ecosystem favors strong documentation and dependable cold-chain or controlled-storage practices where applicable. China has broad chemical and pharmaceutical capabilities, with domestic sourcing, export controls, and qualification requirements varying by application. France, Germany, Italy, and Spain operate within European chemical-safety frameworks and place emphasis on traceability, technical files, and responsible handling. India's pharmaceutical and contract-research sectors support use of specialized intermediates, while supplier qualification and regulatory documentation remain central. Japan and South Korea emphasize precision, quality assurance, and consistent analytical characterization. Mexico benefits from proximity to North American manufacturing networks, although import procedures and local availability can affect procurement. Russia's access conditions may be influenced by trade restrictions, logistics, and supplier-screening requirements. The United Kingdom maintains a strong research base, with post-EU regulatory and customs considerations relevant to sourcing. The United States has extensive discovery and development activity, with rigorous expectations for safety information, quality records, and reliable delivery.

Action Priorities: Build Qualified, Traceable, and Resilient Supply Networks

Industry leaders should establish clear specifications covering identity, assay, impurities, residual solvents, water content, packaging, and storage. Supplier qualification should include independent analytical verification, change-control procedures, batch-history review, and evidence of safe handling. Dual-sourcing or regionally diversified sourcing can reduce disruption exposure, while inventory policies should reflect reactivity, shelf-life, project criticality, and transport constraints. Organizations should also align procurement, research, regulatory, and environmental-health-and-safety teams early in the development cycle. AI tools can improve route selection and quality monitoring, but their use should remain governed by validation, data integrity, and expert oversight.

Research Methodology: Triangulating Chemistry, Regulation, and Supply-Chain Evidence

This executive summary applies a structured qualitative framework to a narrowly defined specialty chemical. The assessment considers the compound's functional-group chemistry, likely research and industrial applications, handling implications, procurement practices, regional infrastructure, regulatory themes, and trade-logistics conditions. Regional, group, and country commentary is based on publicly observable characteristics of chemical manufacturing, pharmaceutical research, laboratory supply, and compliance environments rather than on unpublished commercial claims. No market estimates, market sizes, market shares, forecasts, or company-specific assertions are used. Product identity, purity, form, packaging, and intended use should be confirmed against current supplier documentation and applicable regulations before commercial or laboratory decisions are made.

Conclusion: Technical Assurance and Resilient Procurement Will Define Competitiveness

The outlook for 2-cyano-5-fluorobenzyl bromide is most closely tied to the health of research and specialty-synthesis activity, the ability of suppliers to deliver consistent analytical quality, and the rigor of safety and regulatory management. Geographic differences in infrastructure, import procedures, and compliance expectations make standardized qualification processes especially valuable. Organizations that combine reliable characterization, disciplined storage and handling, diversified sourcing, and carefully governed digital tools will be better positioned to support synthetic programs involving this specialized intermediate.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. New Revenue Opportunities
• 3.4. Next-Generation Business Models
• 3.5. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. 2-Cyano-5-Fluorobenzyl Bromide Market, by Purity Grade

• 7.1. Introduction
• 7.2. Analytical Grade
• 7.3. Industrial Grade
• 7.4. Laboratory Grade

8. 2-Cyano-5-Fluorobenzyl Bromide Market, by Product Type

• 8.1. Introduction
• 8.2. Bulk
• 8.3. Specialty
  • 8.3.1. Custom Synthesis
  • 8.3.2. Tailor-Made Molecules

9. 2-Cyano-5-Fluorobenzyl Bromide Market, by Application

• 9.1. Introduction
• 9.2. Agrochemicals
  • 9.2.1. Fungicide Development
  • 9.2.2. Herbicide Development
  • 9.2.3. Pesticide Synthesis
• 9.3. Pharmaceutical Intermediates
  • 9.3.1. Api Synthesis
  • 9.3.2. Peptide Synthesis
• 9.4. Specialty Chemicals
  • 9.4.1. Dyes And Pigments
  • 9.4.2. Flavors And Fragrances

10. 2-Cyano-5-Fluorobenzyl Bromide Market, by End Use Industry

• 10.1. Introduction
• 10.2. Agricultural
  • 10.2.1. Crop Protection
  • 10.2.2. Seed Treatment
• 10.3. Industrial
  • 10.3.1. Chemical Manufacturing
  • 10.3.2. Material Science
• 10.4. Pharmaceutical
  • 10.4.1. Generic Drug Manufacturing
  • 10.4.2. Novel Drug Development
• 10.5. Research
  • 10.5.1. Academic Research
  • 10.5.2. Contract Research Organizations

11. 2-Cyano-5-Fluorobenzyl Bromide Market, by Distribution Channel

• 11.1. Introduction
• 11.2. Direct Sales
• 11.3. Distributors
  • 11.3.1. National Distributors
  • 11.3.2. Regional Distributors
• 11.4. Online
  • 11.4.1. Company Website
  • 11.4.2. E-Commerce Platforms

12. 2-Cyano-5-Fluorobenzyl Bromide Market, by Region

• 12.1. Introduction
• 12.2. Asia-Pacific
• 12.3. North America
• 12.4. Latin America
• 12.5. Europe
• 12.6. Middle East
• 12.7. Africa

13. 2-Cyano-5-Fluorobenzyl Bromide Market, by Group

• 13.1. Introduction
• 13.2. ASEAN
• 13.3. GCC
• 13.4. European Union
• 13.5. BRICS
• 13.6. G7
• 13.7. NATO

14. 2-Cyano-5-Fluorobenzyl Bromide Market, by Country

• 14.1. Introduction
• 14.2. United States
• 14.3. Canada
• 14.4. Mexico
• 14.5. Brazil
• 14.6. United Kingdom
• 14.7. Germany
• 14.8. France
• 14.9. Russia
• 14.10. Italy
• 14.11. Spain
• 14.12. China
• 14.13. India
• 14.14. Japan
• 14.15. Australia
• 14.16. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2025
• 15.2. Market Concentration Analysis, 2025
  • 15.2.1. Concentration Ratio (CR)
  • 15.2.2. Herfindahl Hirschman Index (HHI)
• 15.3. Recent Developments & Impact Analysis, 2025
• 15.4. Product Portfolio Analysis, 2025
• 15.5. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Beijing InnoChem Science & Technology Co., Ltd.
• 16.2. BLD Pharmatech Ltd.
• 16.3. Changzhou Anxuan Chemical Co., Ltd.
• 16.4. Changzhou Tianrui Pharmaceutical Technology Co., Ltd.
• 16.5. Hebei Chuanghai Biotechnology Co., Ltd.
• 16.6. J & K Scientific Ltd.
• 16.7. Nanjing CHICO Pharmaceutical Co., Ltd.
• 16.8. Ningbo Inno Pharmchem Co., Ltd.
• 16.9. Oakwood Chemical, LLC
• 16.10. Santa Cruz Biotechnology, Inc.
• 16.11. Shaanxi Dideu New Materials Co., Ltd.
• 16.12. Shanghai Yuanye Bio-Technology Co., Ltd.
• 16.13. Sigma-Aldrich (part of Merck KGaA)
• 16.14. SynQuest Laboratories, Inc.
• 16.15. Wuhan Fortuna Chemical Co., Ltd.

17. Key Experts